A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity

Na Tao,Lei Jiao,Huihuang Li,Liu Deng,Wei Wang,Senfeng Zhao,Wansong Chen,Limiao Chen,Chengzhou Zhu,You-Nian Liu

DOI: https://doi.org/10.1021/acsnano.3c07601

IF: 17.1

2023-11-09

ACS Nano

Abstract:The immune checkpoint blockade (ICB) antibody immunotherapy has demonstrated clinical benefits for multiple cancers. However, the efficacy of immunotherapy in tumors is suppressed by deficient tumor immunogenicity and immunosuppressive tumor microenvironments. Pyroptosis, a form of programmed cell death, can release tumor antigens, activate effective tumor immunogenicity, and improve the efficiency of ICB, but efficient pyroptosis for tumor treatment is currently limited. Herein, we show a mild hyperthermia-enhanced pyroptosis-mediated immunotherapy based on hollow carbon nanozyme, which can specifically amplify oxidative stress-triggered pyroptosis and synchronously magnify pyroptosis-mediated anticancer responses in the tumor microenvironment. The hollow carbon sphere modified with iron and copper atoms (HCS-FeCu) with multiple enzyme-mimicking activities has been engineered to induce cell pyroptosis via the radical oxygen species (ROS)-Tom20-Bax-Caspase 3-gasdermin E (GSDME) signaling pathway under light activation. Both <i>in vitro</i> and <i>in vivo</i> antineoplastic results confirm the superiority of HCS-FeCu nanozyme-induced pyroptosis. Moreover, the mild photothermal-activated pyroptosis combining anti-PD-1 can enhance antitumor immunotherapy. Theoretical calculations further indicate that the mild photothermal stimulation generates high-energy electrons and enhances the interaction between the HCS-FeCu surface and adsorbed oxygen, facilitating molecular oxygen activation, which improves the ROS production efficiency. This work presents an approach that effectively transforms immunologically "cold" tumors into "hot" ones, with significant implications for clinical immunotherapy.

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology

What problem does this paper attempt to address?

The core problem that this paper attempts to solve is: How to transform an immunologically "cold" tumor into a "hot" tumor through a new treatment method, thereby enhancing the effect of anti - tumor immunotherapy. Specifically, the paper proposes a mild hyperthermia - enhanced pyroptosis - mediated immunotherapy based on hollow carbon nanozyme (HCS - FeCu) to specifically amplify oxidative - stress - triggered pyroptosis and simultaneously amplify the pyroptosis - mediated anti - cancer response in the tumor microenvironment.

The following are the specific problems solved by the paper:

1. **Improving the effectiveness of immune checkpoint blockade (ICB) therapy**
Immune checkpoint blockade therapy has shown clinical benefits in various cancers, but its efficacy is limited by insufficient tumor immunogenicity and an immunosuppressive tumor microenvironment. The paper attempts to improve the effect of ICB therapy by inducing pyroptosis to release tumor antigens and activate effective tumor immunogenicity.

2. **Overcoming the limitations of traditional pyroptosis - induction methods**
Currently, there are limited highly - effective pyroptosis methods for tumor treatment. In particular, chemical drugs such as cisplatin, topotecan, and mitoxantrone have drug resistance and significant toxic and side effects. The paper proposes a safer and more efficient pyroptosis - induction strategy.

3. **Utilizing the relationship between oxidative stress and pyroptosis**
Pyroptosis is closely related to the intracellular and extracellular environment, especially highly related to the tumor oxidative - stress level. The paper induces pyroptosis by regulating the oxidative - stress balance while avoiding cell tolerance to oxidative stress.

4. **Combining mild hyperthermia and pyroptosis**
Mild hyperthermia has been proven to stimulate the immune system, activate T - cell initiation and infiltration, and promote the immune response. The paper explores a method to amplify oxidative - stress - triggered pyroptosis and simultaneously amplify the pyroptosis - mediated anti - cancer response under mild hyperthermia conditions.

### Core mechanisms of the solution:
- **Material design**: Developed a hollow carbon - sphere nanozyme (HCS - FeCu) modified with iron and copper atoms, which has multiple enzyme - mimicking activities.
- **Pyroptosis pathway**: Induces cell pyroptosis through the ROS - Tom20 - Bax - Caspase 3 - GSDME signaling pathway.
- **Photothermal effect**: Mild photothermal stimulation generates high - energy electrons, enhances the interaction between the HCS - FeCu surface and adsorbed oxygen, promotes molecular oxygen activation and improves ROS generation efficiency.
- **Immune activation**: The pyroptosis process releases tumor antigens, activates the adaptive immune system, and synergistically enhances the effect of ICB therapy.

### Formula summary (key mechanisms involved):
1. **ROS generation and pyroptosis pathway**:
$$
\text{ROS} \xrightarrow{\text{Tom20 - Bax}} \text{Caspase 3} \xrightarrow{\text{GSDME}} \text{Pyroptosis}
$$
2. **Photothermal conversion efficiency**:
$$
\eta=\frac{C_p\cdot\Delta T}{I\cdot t}
$$
where $\eta$ is the photothermal conversion efficiency, $C_p$ is the specific heat capacity, $\Delta T$ is the temperature change, $I$ is the laser intensity, and $t$ is the irradiation time.
3. **Enzyme - catalyzed kinetics**:
According to the Michaelis - Menten equation:
$$
v = \frac{V_{\text{max}}[S]}{K_m+[S]}
$$
where $v$ is the reaction rate, $V_{\text{max}}$ is the maximum reaction rate, $[S]$ is the substrate concentration, and $K_m$ is the Michaelis constant.

Through these mechanisms, the paper proposes a new method to transform "cold" tumors into "hot" tumors, providing important inspiration for clinical immunotherapy.